Probo Medical Names Mike Dilick CEO to Drive Next Phase of Growth

Probo Medical, a global leader in diagnostic imaging solutions, has appointed Mike Dilick as Chief Executive Officer, effective January 1, 2026, to accelerate the company's growth and innovation. Dilick joined Probo Medical in 2018 and has played a pivotal role in expanding the company's commercial footprint as President and Chief Commercial Officer. With more than

MSC Income Fund Announces Fourth Quarter 2025 Private Loan Portfolio Activity

MSC Income Fund, Inc. (NYSE: MSIF) (“MSC Income” or the “Fund”) is pleased to announce the following recent activity in its private loan portfolio. During the fourth quarter of 2025, MSC Income originated new or increased commitments in its private loan portfolio of $131.8 million and funded total investments across its private loan portfolio with

Obita Completes Pre-A Round, Raising Nearly US$30 Million Across Two Rounds

Obita has completed its Pre-A financing round, bringing its total funding across two rounds to nearly US$30 million. The round was led by Monolith, with existing shareholders including Vision Plus Capital, Mirana Ventures and Legend Capital continuing to increase their investments. Proceeds will be used to accelerate business growth and further build Obita's global, enterprise-grade

OLD REPUBLIC ANNOUNCES FOURTH QUARTER 2025 EARNINGS CALL

Old Republic International Corporation (NYSE: ORI) – today announced that it will report financial results for the fourth quarter of 2025 before the market opens on Thursday, January 22, 2026, and will hold a conference call at 3:00 p.m. Eastern time to discuss results. The call can be accessed live on Old Republic's website at

AIResumeBuilder.com Survey: 9 in 10 Gen Z Can’t Imagine Life Without ChatGPT

For many young adults, ChatGPT is becoming as essential as the internet itself A new survey from AIResumeBuilder.com reveals that 9 in 10 Gen Zers say they're reliant on ChatGPT and similar conversational AI tools, suggesting that conversational AI may now be as essential to daily life as social media, if not more. In December

Cloopen Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee

Cloopen Group Holding Limited (OTC: RAASY) (“Cloopen” or the “Company”) today announced that the special committee (the “Special Committee”) of the Company's board of directors (the “Board”), which was formed to evaluate and consider the previously announced preliminary non-binding proposal letter dated December 22, 2025 (the “Proposal”), has retained Kroll, LLC as its financial advisor,

RVL Pharmaceuticals Announces Santen Obtains Manufacturing and Marketing Approval in Japan for UPNEEQ® Mini Ophthalmic Solution 0.1%

RVL Pharmaceuticals, Inc. and its affiliates (together, “RVL”) announces Santen Pharmaceutical Co., Ltd. (“Santen”), a leading ophthalmology company has obtained the manufacturing and marketing approval in Japan for UPNEEQ® Mini Ophthalmic Solution 0.1% (generic name: oxymetazoline hydrochloride; development code: STN1013800; hereinafter the product), a treatment for acquired blepharoptosis (low-lying eyelids). This milestone expands access in

Dunlop Aircraft Tyres Appoints Lee Timbrell as Chief Commercial Officer

Veteran Aerospace Aftermarket Sales Executive to Advance Global Commercial Strategy Dunlop Aircraft Tyres (“Dunlop”), a leading independent global designer and manufacturer of high-performance aircraft tyres serving the commercial, military and freighter aircraft markets, announced today the appointment of Lee Timbrell as Chief Commercial Officer. In his new role, Mr. Timbrell will lead the company's global

Main Street Announces Fourth Quarter 2025 Private Loan Portfolio Activity

Main Street Capital Corporation (NYSE: MAIN) (“Main Street”) is pleased to announce the following recent activity in its private loan portfolio. During the fourth quarter of 2025, Main Street originated new or increased commitments in its private loan portfolio of $387.1 million and funded total investments across its private loan portfolio with a cost basis

Scroll to Top